Literature DB >> 13535735

Enzymes of uracil metabolism in the Ehrlich ascites tumour and mammalian liver.

P REICHARD, O SKOLD.   

Abstract

Entities:  

Keywords:  LIVER/metabolism; NEOPLASMS/metabolism; URACIL/metabolism

Mesh：

Substances：

Year:  1958        PMID： 13535735     DOI： 10.1016/0006-3002(58)90485-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  10 in total

1.  Pyrimidine metabolism in man. I. The biosynthesis of orotic acid.

Authors:  L H SMITH; F A BAKER
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

2.  PYRIMIDINE METABOLISM IN MAN. IV. THE ENZYMATIC DEFECT OF OROTIC ACIDURIA.

Authors:  L H Smith; M Sullivan; C M Huguley
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

3.  Uridine kinase activities in developing, adult and neoplastic rat tissues.

Authors:  A Herzfeld; S M Raper
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

4.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

5.  Uridine kinase activities and pyrimidine nucleoside phosphorylation in fluoropyrimidine-sensitive and -resistant cell lines of the Novikoff hepatoma.

Authors:  N Greenberg; D E Schumm; T E Webb
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

6.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

7.  Anabolism versus catabolism of [5-3H]uridine and its relationship to ribonucleic acid labelling in mouse liver after partial hepatectomy.

Authors:  T Yngner; C Engelbrecht; L Lewan; J E Annerfeldt
Journal:  Biochem J       Date:  1979-01-15       Impact factor: 3.857

8.  Specific activities of uridine phosphorylase and uridine kinase in Ehrlich ascites carcinoma cells and 6-azauracil- and 6-azauridine-treated sublines in successive transplant generations.

Authors:  D G Blair; A D Hall
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

9.  AZO-DYE CARCINOGENESIS: ENZYMES CONCERNED IN URIDINE NUCLEOTIDE METABOLISM.

Authors:  E REID
Journal:  Br J Cancer       Date:  1964-03       Impact factor: 7.640

Review 10.  Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases.

Authors:  An R Van Rompay; Magnus Johansson; Anna Karlsson
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.